Production (Stage)
AIM ImmunoTech Inc.
AIMI
$0.0849
-$0.0001-0.12%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 170.00K | 190.00K | 201.00K | 193.00K | 202.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 170.00K | 190.00K | 201.00K | 193.00K | 202.00K |
| Cost of Revenue | 31.00K | 36.00K | 58.00K | 50.00K | 42.00K |
| Gross Profit | 139.00K | 154.00K | 143.00K | 143.00K | 160.00K |
| SG&A Expenses | 13.90M | 20.54M | 22.90M | 22.86M | 21.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.94M | 28.11M | 31.79M | 33.55M | 32.12M |
| Operating Income | -19.77M | -27.92M | -31.59M | -33.36M | -31.92M |
| Income Before Tax | -17.32M | -23.93M | -28.05M | -31.12M | -28.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.32 | -23.93 | -28.05 | -31.12 | -28.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.32M | -23.93M | -28.05M | -31.12M | -28.96M |
| EBIT | -19.77M | -27.92M | -31.59M | -33.36M | -31.92M |
| EBITDA | -19.53M | -27.68M | -31.36M | -33.11M | -31.68M |
| EPS Basic | -0.31 | -0.47 | -0.57 | -0.64 | -0.59 |
| Normalized Basic EPS | -0.19 | -0.30 | -0.36 | -0.40 | -0.37 |
| EPS Diluted | -0.31 | -0.48 | -0.57 | -0.64 | -0.60 |
| Normalized Diluted EPS | -0.19 | -0.30 | -0.36 | -0.40 | -0.37 |
| Average Basic Shares Outstanding | 223.99M | 208.86M | 199.82M | 195.39M | 194.34M |
| Average Diluted Shares Outstanding | 223.99M | 208.86M | 199.82M | 195.39M | 194.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |